Phase I studies on chlorozotocin.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 148344)

Published in Clin Pharmacol Ther on June 01, 1978

Authors

D Hoth, P Woolley, D Green, J Macdonald, P Schein

Articles citing this

Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice. J Clin Invest (1979) 0.80

Articles by these authors

(truncated to the top 100)

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (1995) 11.89

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14

A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost (1981) 4.39

Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J (1998) 4.14

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol (1998) 3.79

Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med (1975) 3.36

Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A (1997) 3.30

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med (1992) 3.23

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation (1997) 2.80

Distribution, diversity, and host specificity of Bartonella in rodents from the Southeastern United States. Am J Trop Med Hyg (1997) 2.77

A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med (1993) 2.76

Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell (1996) 2.66

Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med (1990) 2.63

Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med (1997) 2.59

Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol (1998) 2.57

Decedents' reported preferences for physician-assisted death: a survey of informants listed on death certificates in Utah. J Clin Ethics (1995) 2.10

Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh (1975) 2.10

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J Clin Oncol (1998) 2.05

Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol (1985) (2001) 2.02

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med (1998) 1.98

Evaluation of prenatal care information on birth certificates. Paediatr Perinat Epidemiol (1997) 1.97

The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes. J Am Coll Cardiol (2001) 1.95

Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol (1985) 1.95

5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med (1980) 1.95

Pitfalls in the evaluation of ablative therapy for telangiectases. Dermatol Surg (1998) 1.91

Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep (1986) 1.91

Mesenteric venous thrombosis. J Vasc Surg (1989) 1.86

Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab (2000) 1.85

Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med (1999) 1.82

Kinetics of the human renin and human substrate reaction. Cardiovasc Res (1971) 1.75

Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol (2011) 1.74

Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity. Diabetologia (2006) 1.72

Biogeography and ecological setting of Indian Ocean hydrothermal vents. Science (2001) 1.69

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Electrostatic interactions at charged lipid membranes. I. Effects of pH and univalent cations on membrane structure. Biophys Chem (1976) 1.56

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis (1998) 1.55

HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis (1992) 1.52

Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program. JAMA (1988) 1.51

The role of cerebral oximetry in combination with awake testing in patients undergoing carotid endarterectomy under local anaesthesia. Eur J Vasc Endovasc Surg (2011) 1.50

Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet (1975) 1.49

Isolation of Japanese encephalitis virus from mosquitoes (Diptera: Culicidae) collected in the Western Province of Papua New Guinea, 1997-1998. Am J Trop Med Hyg (2000) 1.48

Acquired hemophilia. Rev Clin Exp Hematol (2001) 1.48

Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost (2006) 1.46

Point mutations regarded as missense mutations cause splicing defects in the factor XI gene. J Thromb Haemost (2011) 1.46

Amyloidosis in association with human immunodeficiency virus infection. Clin Infect Dis (1992) 1.45

Safety and feasibility of an insulin adjustment protocol to maintain blood glucose concentrations within a narrow range in critically ill patients in an Australian level III adult intensive care unit. Crit Care Resusc (2004) 1.44

An association between the flat back and postpolio syndromes: a report of three cases. Arch Phys Med Rehabil (1997) 1.44

Successful intravenous immune globulin therapy for human immunodeficiency virus-associated thrombocytopenia. Arch Intern Med (1988) 1.41

Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. Genitourin Med (1997) 1.41

Double canals in single roots. Oral Surg Oral Med Oral Pathol (1973) 1.41

Longitudinal study of adrenal steroids in a cohort of HIV-infected patients with hemophilia. J Lab Clin Med (1996) 1.40

A different view of "Toc", as I knew him. J Thromb Haemost (2003) 1.40

Cardiovascular function and the veteran athlete. Eur J Appl Physiol (2010) 1.40

The South African Pilot Hospital Accreditation Programme. Part II. The development of standards. S Afr Med J (1994) 1.39

Treatment of leg veins. Dermatol Surg (1999) 1.39

Heterotopic ossification pseudophlebitis. Am J Med (1989) 1.39

CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg (1982) 1.38

Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect (2004) 1.37

The South African Pilot Hospital Accreditation Programme. Part I. The process. S Afr Med J (1994) 1.36

Successful management of the Sézary syndrome. Mobilization and removal of extravascular neoplastic T cells by leukapheresis. N Engl J Med (1974) 1.35

Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant. Thromb Haemost (1983) 1.34

Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective. Arch Intern Med (1997) 1.34

Host immunity to repeated rabies virus infection in big brown bats. J Gen Virol (2010) 1.33

The performance of a CCD digital autoradiography imaging system. Phys Med Biol (2000) 1.32

The appearance of a second genotype of Japanese encephalitis virus in the Australasian region. Am J Trop Med Hyg (2001) 1.32

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin. Lancet (1992) 1.29

Distributed situation awareness in dynamic systems: theoretical development and application of an ergonomics methodology. Ergonomics (2006) 1.29

Prognostic factors in Burkitt's lymphoma: importance of total tumor burden. Cancer (1980) 1.29

A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology (2001) 1.28

Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost. Am J Public Health (1996) 1.28

A putative role for nicotinamide adenine dinucleotide-promoted nuclear protein modification in the antitumor activity of N-methyl-N-nitrosourea. Cancer Res (1977) 1.27

Deep vein thrombosis in spinal cord injury: effect of prophylaxis with calf compression, aspirin, and dipyridamole. Paraplegia (1982) 1.24

Sequential changes in factor VIII and platelets preceding deep vein thrombosis in patients with spinal cord injury. Br J Haematol (1980) 1.24

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

Structural characterization and alternate splicing of the gene encoding the preadipocyte EGF-like protein pref-1. Biochemistry (1994) 1.23

Evidence for a role of oxygen derived free radicals in the pathogenesis of caerulein induced acute pancreatitis in rats. Gut (1988) 1.22

Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest (1997) 1.22

Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer (1990) 1.21

Electrostatic interactions at charged lipid membranes. Hydrogen bonds in lipid membrane surfaces. Biophys Chem (1979) 1.21

Combined aerobic and resistance exercise training improves functional capacity and strength in CHF. J Appl Physiol (1985) (2000) 1.20

Comparison of temporal filtering methods for dynamic contrast MRI myocardial perfusion studies. Magn Reson Med (2003) 1.20

Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Hum Pathol (2000) 1.20

Low-molecular-weight heparin in the management of Trousseau's syndrome. Cancer (1997) 1.20

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

A note on the temperature tolerance of Legionella. J Appl Bacteriol (1984) 1.18

5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. Cancer (1979) 1.17

An extra small metacentric chromosome identified as a deleted chromosome no. 17. Clin Genet (1976) 1.17

Coagulation changes in individuals with sickle cell trait. Am J Hematol (2002) 1.16

MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer. Br J Cancer (1996) 1.16

The cytotoxin of Actinobacillus pleuropneumoniae (pleurotoxin) is distinct from the haemolysin and is associated with a 120 kDa polypeptide. J Gen Microbiol (1991) 1.15

New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res (1999) 1.14

Movement of the 3'-end of tRNA through the peptidyl transferase centre and its inhibition by antibiotics. FEBS Lett (1997) 1.14

Cross-sectional echocardiographic characterization of aortic obstruction. 1. Supravalvular aortic stenosis and aortic hypoplasia. Circulation (1978) 1.14

Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost (2004) 1.14

Referral patterns to a University-based cardiac rehabilitation program. Am J Cardiol (1999) 1.14

Erythema multiforme and Stevens-Johnson syndrome. Descriptive and therapeutic controversy. Chest (1990) 1.13

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides. J Med Chem (1998) 1.12

Interactions between dihydropyridine receptors and ryanodine receptors in striated muscle. Prog Biophys Mol Biol (2002) 1.12